Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553240 · ClinicalTrials.gov registry record · NA
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
A NA study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01553240 is a NA study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 8 participants.
The verdict
NCT01553240, a NA study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study uses functional brain imaging and noninvasive brain stimulation techniques to study the brain basis of developmental disorders like Autism Spectrum Disorder and Asperger Disorder. Functional magnetic resonance imaging (fMRI) and recently approved FDA treatment of depression, Transcranial magnetic stimulation (TMS) will be used to study the neurocircuitry of certain symptom clusters in developmental disorders.
Interventions
- DEVICE TMS and functional MRI (Magstim)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01553240
The ClinicalTrials.gov registry entry for NCT01553240 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TMS and functional MRI (Magstim) is the first listed.
NCT01553240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01553240 about?
NCT01553240 is a clinical study titled "Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies". This study uses functional brain imaging and noninvasive brain stimulation techniques to study the brain basis of developmental disorders like Autism Spectrum Disorder and Asperger Disorder. Functional magnetic resonance imaging (fMRI) and recently approved FDA treatment of depression, Transcranial ...
What is the current status of trial NCT01553240?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2007-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01553240?
The interventions under investigation include: TMS and functional MRI (Magstim) (DEVICE).
Who is sponsoring clinical trial NCT01553240?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.